Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus
about
Biology of parainfluenza virusesRespiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunityImmunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetesAntibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaquesAnalysis of Human RSV Immunity at the Molecular Level: Learning from the Past and PresentVbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSVA recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus.Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatmentSendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challengeCell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus.Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice.Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challengeImmune responses and disease enhancement during respiratory syncytial virus infectionComplement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus.Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.New insights for development of a safe and protective RSV vaccineHyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus diseaseImmunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infectionRespiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton ratsThe use of a neonatal mouse model to study respiratory syncytial virus infections.Small Animal Models for Human Metapneumovirus: Cotton Rat is More Permissive than Hamster and Mouse.Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles.Novel drugs targeting Toll-like receptors for antiviral therapy.Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV.Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice.Respiratory syncytial virus binds and undergoes transcription in neutrophils from the blood and airways of infants with severe bronchiolitis.Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging studyCharacterization of human metapneumovirus infection of myeloid dendritic cellsHuman metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats.Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern.Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV.A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton ratsVirus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virusA role for immune complexes in enhanced respiratory syncytial virus disease.Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates
P2860
Q24615805-FD9F9190-9303-4A48-ABBB-B61AE1A06D38Q24676109-9EED3BC5-D648-4EF8-AC42-F4FA2FC091C2Q27011799-534292EF-6A01-40B1-837E-1CEE78B43ADCQ27486549-AFDCC1FD-600A-477A-8353-98609C6022ECQ28080556-412BFF43-18AC-4DA9-BADD-E3F86D1BEF5DQ30448968-26E3DFB2-7B5A-44E4-8764-05A49FA892F4Q33578748-7BA1B909-1FFC-4ED2-8AB8-9B58BF2B4D4DQ33588916-250C2897-146F-4EA2-B9E7-42E06866947CQ33724997-1A38BF95-9D61-4122-8EE8-7AC1E5759BEBQ33783066-B6E2EB61-1C7F-44CC-B1D2-E5C35E344AFEQ33784028-0A6A7DCC-F384-411A-959D-DB195C101A3BQ33870528-325EB594-90B6-4781-8AF2-910D975355B5Q33928414-013F8F0A-63E0-4C8D-BF4C-241D12C13AE4Q33937152-5741DDEE-7C5A-4DD8-8272-05EDC75D9667Q33937698-42212BE9-B350-4D91-AA93-A3CCE8E79EBDQ34151000-762B81FE-3EE2-48C6-BB94-6013556856CBQ34249859-05776D01-C495-42C6-8245-BC5A17A7513EQ34307704-A9246968-8258-4523-A451-F852EFC912DBQ34330690-0B667318-8C07-452E-8ECA-838947386A0FQ34355131-244F2D7C-BC09-41A9-9054-6BA319C930B5Q34506016-DDB2EFA4-7436-44DB-8DC7-5A35540F8AF9Q34549253-2867EB9E-D85E-4E59-B21B-A4670F97C475Q34569141-A9DC3CC8-EF81-4736-A4F8-B63628FB87BFQ34791209-D45BF16B-220D-4DE7-AA2B-05F5EF35BAA7Q34948645-673FC6E8-B593-4240-AB21-A05742BF1818Q34999938-4DEC3B02-EB24-4243-9B49-CD46D95FAFD4Q35063967-CB7E6874-887F-4CEB-AC56-DA8AA758CAA3Q35077892-DF7139DE-5A69-45C2-84C3-DC664F39AC89Q35093298-1E2E2208-079A-4E03-8927-B48A1228054AQ35487966-B95D2D87-469C-4EDC-9365-8257C2E2ABC4Q35585877-55EA4F09-5C2C-49D7-B8D6-433A8AEFEF84Q35634929-A91127C4-F020-43A2-AEFB-5E01B28B80F0Q35859950-F2D72189-6A2A-4E8E-9CC0-3C575B1F6A9FQ35892441-D860F85B-DC71-4148-BD02-BBF730B8860AQ36251566-DDC58EDB-6E72-4DF5-9106-163B418A889BQ36281893-7D0A62AC-2266-4475-AE37-0FEB5C672E3EQ36315159-0456AEA3-0D23-4A69-9A91-5933C00A81C3Q36355326-1E7C0ABD-8CC4-4133-A15B-2E69C98DB45FQ36371267-0EC648C3-2F44-4F56-8F62-20881DF8F61DQ36515541-C2B1B1BB-65EE-419B-B3F0-E594A7AEB8A7
P2860
Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Enhancement of respiratory syn ...... of formalin-inactiva ted virus
@en
type
label
Enhancement of respiratory syn ...... of formalin-inactiva ted virus
@en
prefLabel
Enhancement of respiratory syn ...... of formalin-inactiva ted virus
@en
P2093
P2860
P1433
P1476
Enhancement of respiratory syn ...... of formalin-inactiva ted virus
@en
P2093
Chanock RM
Hemming VG
Horswood RL
P2860
P304
P407
P577
1986-03-01T00:00:00Z